Francesco Marincola
About Francesco Marincola
Francesco Marincola serves as the Global Head of Research at Kite Pharma and has extensive experience in immunology and genetics. He has held various leadership roles in research organizations and has authored over 600 peer-reviewed publications.
Work at Kite Pharma
Francesco Marincola has served as the Global Head of Research at Kite Pharma since 2021. In this role, he leads the research organization focused on identifying novel therapies for hematologic malignancies and solid tumors. His leadership aims to advance the development of innovative treatments in the field of oncology.
Education and Expertise
Francesco Marincola studied at the University of Milan, where he earned a Medical Doctor degree with a focus on Immunology and Genetics from 1972 to 1978. His educational background provides a strong foundation for his extensive career in medical research and immunotherapy.
Background
Before joining Kite Pharma, Marincola worked for 23 years at the National Institutes of Health (NIH) in Bethesda, Maryland, as a Tenured Investigator. His career also includes roles as Chief Scientific Officer at Refuge Biotechnologies and Chief Research Officer at Sidra Medical and Research Center, where he has contributed significantly to the field of immuno-oncology.
Achievements
Francesco Marincola has authored over 600 peer-reviewed publications and has held prominent positions in various organizations. He served as the former President of the Society for Immunotherapy of Cancer (SITC) and has been a Distinguished Research Fellow in Immune Oncology at AbbVie. Additionally, he currently serves as Editor-in-Chief for several peer-reviewed journals, including the Journal of Translational Medicine.
Current Roles
In addition to his role at Kite Pharma, Francesco Marincola is currently the Chief Scientific Officer at Sonata Therapeutics, a position he has held since 2023. He also continues to serve as President and Chief Scientific Officer at Refuge Biotechnologies, where he has been since 2018. His diverse roles reflect his ongoing commitment to advancing research in the field of biotechnology.